Fludarabine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Fludarabine. Educational only — not medical advice.
Labeled uses
Fludarabine Phosphate for Injection is indicated for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. The safety and effectiveness of Fludarabine Phosphate for Injection in previously untreated or non-refractory patients with CLL have not been established.
Source: FDA labeling via NIH DailyMed (set 3adca34b…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.